Clarivate

JUNE 28, 2022

Today we release the 2022 update to the annual Journal Citation Reports (JCR). This year’s release demonstrates the enormous impact the COVID-19 pandemic has had on scholarly publishing. We also identify and define a new type of anomalous citation behavior: self-stacking. The annual JCR release enables the research community to evaluate the world’s high-quality academic journals using a range of indicators, descriptive data and visualizations.

Medicine 141

Medicine Government Leads Medical 141

MedCity News

JUNE 28, 2022

Obese patients are more at risk for diabetes, cardiovascular disease, certain cancers and mortality than patients who maintain a healthy weight, and obese patient who develop these chronic conditions usually have more complications. That is why providers and payers must integrate more weight loss strategies in chronic condition care, panelists argued at a Tuesday panel hosted by the Chamber of Commerce.

Patients 128

Patients 128

PM360

JUNE 28, 2022

The Creative Floor Healthcare Awards has announced this year’s finalists. Entries have come from the U.S., South America, UK, EU, Australia, Japan, New Zealand, Philippines, Singapore, China, and the Middle East. The finalist companies include: Shaheed Peera, Founder of the Creative Floor Healthcare Awards said: “From the bottom of my heart and everyone at The Creative Floor, thank you to everyone who supports this amazing award show.

Healthcare 116

Healthcare Healthcare 116

MedCity News

JUNE 28, 2022

Astellas Pharma has a new partner in the R&D of a type of cancer drug called an antibody drug conjugate (ADC). The Japanese pharma company reached across the Pacific Ocean to collaborate with Sutro Biopharma in a bet that Bay Area-based firm’s technology can deliver more powerful ADCs.

Biopharma 114

Biopharma Pharma 114

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Distribution

Medgadget

JUNE 28, 2022

Percutaneous coronary intervention is an incredibly useful technique to minimally invasively investigate and treat cardiac issues, such as blockages in the coronary arteries, but it requires a significant amount of skill to perform safely and effectively. Manipulating a guidewire through the tortuous vasculature is not for the faint hearted, with the possibility of perforating a vessel always near.

Physicians 109

Physicians Engineering Leads Training 109

Pharmaceutical Technology

JUNE 28, 2022

Astellas Pharma and Sutro Biopharma have entered a global, strategic partnership and licencing agreement to discover and develop new immunostimulatory antibody-drug conjugates (iADCs). An iADC merges an antibody with a small molecule compound that elicits immunogenic cell death, and an immune-activating molecule. It can potentially enhance the anti-cancer effect.

Biopharma 105

Biopharma Engineering Marketing Pharma 105

pharmaphorum

JUNE 28, 2022

Astellas has agreed a $1.36 billion partnership with US biotech Sutro Biopharma for a series of antibody-drug conjugates for cancer, focusing on applications in patients who don’t respond to current immunotherapies. The alliance includes an upfront payment of $90 million, backed by $422.5 million in possible milestone payments apiece for up to three development programmes based on Sutro’s immunostimulatory antibody-drug conjugate (iADC) technology.

Biopharma 102

Biopharma Patients FDA Marketing 102

Pharmaceutical Commerce

JUNE 28, 2022

Amy Shortman outlines some ways visibility technology is solving problems at a time when it’s needed most, and how digitization is the key to overcoming supply chain crises.

98

98

MedCity News

JUNE 28, 2022

Sanofi won European Commission approval for two therapies that treat rare enzyme deficiencies. Xenpoyzme is the first treatment for acid sphingomyelinase deficiency (ASMD) while Nexviadyme is a successor to a blockbuster Sanofi drug for Pompe disease.

FDA 97

FDA Biopharma Pharma 97

PharmaTech

JUNE 28, 2022

Samsung Biologics is responding to industry challenges with various development projects and services that improve overall timelines and efficiencies when manufacturing new medicines.

Manufacturing 92

Manufacturing Medicine 92

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

MedCity News

JUNE 28, 2022

A webinar sponsored by Carta Healthcare, scheduled for Wednesday, July 20, will highlight the role of AI in mining patient data and ways to improve it.

Electronics 97

Electronics Medical Healthcare Healthcare 97

European Pharmaceutical Review

JUNE 28, 2022

New data reveals that more relapsing multiple sclerosis (RMS) patients continuously treated with Kesimpta ® (ofatumumab) had no evidence of disease activity (NEDA) versus switching from teriflunomide. 1. The Phase III Asclepios I/II trials and the Alithios open-label extension from Novartis , showed that earlier initiation with Kesimpta resulted in a more than three-fold increased likelihood of maintaining NEDA-3 throughout the study.

Patients 81

Patients Physicians Pharmaceutical 81

MedCity News

JUNE 28, 2022

The company is making its online staffing platform available to people seeking jobs as physical therapists, surgical techs and other allied health professions.

Marketing 96

Marketing 96

PharmaVoice

JUNE 28, 2022

The hormonal and genetic test developed by Adyn is designed to predict and prevent adverse birth control side effects.

Side effects 91

Side effects 91

Advertisement

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

Specialization

MedCity News

JUNE 28, 2022

Socially Determined, a healthcare analytics startup focused on social determinants of health insights, closed a $26 million funding round on Tuesday. It will used the funds to expand its customer base, which comprises health plans, health systems and life sciences organizations.

Healthcare 87

Healthcare Healthcare 87

European Pharmaceutical Review

JUNE 28, 2022

HIGHLY POTENT active pharmaceutical ingredients (HPAPIs) products are classified based on their toxicity through occupational exposure limits (OELs). These molecules are proven to be effective at much smaller dosage levels than traditional APIs. Some examples of HPAPIs are cytotoxic compounds and hormones such as oestrogen. What defines ‘high potency’?

Pharmacology 73

Pharmacology Pharmaceutical 73

MedCity News

JUNE 28, 2022

In a wide-ranging discussion, Amwell Chairman & CEO Ido Schoenberg expressed frustration at being lumped together with other telehealth companies that have very different approaches and business models. But he was also very optimistic about the category overall.

75

75

MedReps

JUNE 28, 2022

As a current or aspiring medical sales representative, you may be wondering about the best way to present your skills and experience on your resume. A chronological resume may be the right choice for you. It’s one of the best options because it saves time for recruiters. Because they get the information related to your most recent job or greatest achievement at the top, it becomes easy to follow your work and study history.

Medical sales reps 70

Medical sales reps Medical sales Sales Medical 70

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Safety

European Pharmaceutical Review

JUNE 28, 2022

The post Guide to Data Integrity appeared first on European Pharmaceutical Review.

Pharmaceutical 103

Pharmaceutical 103

Pharmaceutical Technology

JUNE 28, 2022

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended granting approval for AstraZeneca and Merck’s (MSD outside the US and Canada) Lynparza (olaparib) as adjuvant therapy for high-risk early breast cancer patients. The treatment is intended for breast cancer patients with germline BRCA-mutated (gBRCAm), human epidermal growth factor receptor 2 (HER2)-negative who have previously received neoadjuvant or adjuvant chemotherapy.

Safety 64

Safety Medicine Patients Medical 64

Copyright Clearance Center

JUNE 28, 2022

The post Data-Driven Decisions Start with Building Trust appeared first on Copyright Clearance Center.

100

100

Pharmaceutical Technology

JUNE 28, 2022

Researchers at the Rensselaer Polytechnic Institute in the US have received a five-year, $3.5m grant from the National Institutes of Health (NIH) unit National Institute of Allergy and Infectious Diseases (NIAID) for developing a Covid-19 oral antiviral drug. The antiviral will be a low-dose drug which can be taken in the at-home setting. The latest research is part of the consortium of a new antiviral drug development centre named Center for Antiviral Medicines and Pandemic Preparedness (CAMPP)

Food and Drug Administration 59

Food and Drug Administration Medicine Food FDA 59

Advertisement

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

Management

PharmaTimes

JUNE 28, 2022

New data will be released at the International Society on Thrombosis and Haemostasis Congress

84

84

PharmaVoice

JUNE 28, 2022

A new report from IQVIA reveals the current challenges — and promise — in cancer drug R&D.

Marketing 75

Marketing 75

PharmaTimes

JUNE 28, 2022

The mobile clinics will support communities with limited or no access to vaccines and other health services

75

75

Cesare Ferrari

JUNE 28, 2022

“The customer is NOT always right;” does that surprise you? The “customer is king” and “the customer is always right” are two well known sentences that are frequently used in the business community and not only. Although I have maximum respect for customers and advocate for customer centricity , customer focus, etc., I do not believe that the customer is always right and should always be treated like a king.

Prospecting 52

Prospecting Retail Medical Doctors 52

Advertisement

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

Leads

Evolve Your Success

JUNE 28, 2022

In this second segment of a two-part interview, serial entrepreneur Jeff Smith shares how he found his passion and mission through pharmaceutical sales. He now provides consulting and advisory services to companies using innovation and technologies to solve problems. With the lessons learned from his early ventures, he is set to build a great business with an awesome team, continue innovating, tell the right story to their customers, and leverage social media. — Watch the episode here.

Sales 52

Sales Pharma Medical sales reps Medical sales 52

Quantified

JUNE 28, 2022

Pinpointing the difference between sales managing, training, and coaching can be difficult. Although they’re often used interchangeably, each one means something different. The main difference is the delivery and desired outcome of the approach. Training focuses on a specific set of skills and isn’t necessarily a 1:1 approach between a manager and employee.

Sales Management 52

Sales Management Training Management Sales 52

Pharmaceutical Technology

JUNE 28, 2022

Mentions of robotics within the filings of companies in the pharmaceutical industry fell 22% between the final quarter of 2021 and the first quarter of 2022. In total, the frequency of sentences related to robotics between April 2021 and March 2022 was as frequent as in 2016 when GlobalData, from whom our data for this article is taken, first began to track the key issues referred to in company filings.

Pharmaceutical 52

Pharmaceutical 52

Clarivate

JUNE 28, 2022

The metaverse and non-fungible tokens (NFTs) trends are increasingly driving trademark filing activity. These virtual world developments continue to impact how Intellectual Property (IP) is created, managed and protected. We discussed this topic in our recent IP Forum and continue the conversation here, which is the first of a three-part blog series.

Government 52

Government Professional Services Management Manufacturing 52

Advertisement

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.

Patients